Valuation: GlaxoSmithKline plc

Market Cap 75.75B 103B 88.52B 82.84B 143B 9,884B 144B 980B 381B 4,964B 387B 379B 16,427B P/E 2026 *
14.3x
P/E 2027 * 11.7x
Enterprise Value 95.59B 130B 112B 105B 180B 12,472B 182B 1,237B 481B 6,264B 489B 479B 20,728B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.61x
Free-Float
92.75%
Yield 2026 *
3.68%
Yield 2027 * 3.96%
Manager TitleAgeSince
Chief Executive Officer 52 31/12/2025
Director of Finance/CFO 64 30/04/2023
Compliance Officer - 31/07/2018
Director TitleAgeSince
Director/Board Member 52 05/05/2026
Director/Board Member 64 31/12/2017
Chairman 67 31/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-0.40% - - 105B
-0.67%+5.66%+75.21%+125.34% 1,119B
+1.04%+4.87%+52.29%+65.95% 651B
-0.17%+6.04%+25.60%+79.85% 468B
-1.38%+4.31%+41.64%+41.08% 374B
-0.52%+3.53%+24.32%+40.27% 302B
-1.06%+5.67%+1.19%+12.44% 259B
+1.03%+6.90%+51.11%+72.46% 238B
-0.53%+1.54%-17.77%-54.10% 208B
+0.42%+6.06%+27.86%+90.47% 181B
Average -0.18%+5.17%+31.27%+52.64% 422.21B
Weighted average by Cap. -0.23%+5.40%+43.93%+72.03%

Financials

2026 *2027 *
Net sales 33.94B 46.26B 39.65B 37.11B 64.03B 4,428B 64.7B 439B 171B 2,224B 174B 170B 7,359B 35.52B 48.42B 41.5B 38.84B 67.01B 4,634B 67.71B 459B 179B 2,327B 182B 178B 7,701B
Net income 5.44B 7.41B 6.35B 5.94B 10.26B 709B 10.36B 70.32B 27.33B 356B 27.79B 27.22B 1,179B 6.48B 8.84B 7.58B 7.09B 12.23B 846B 12.36B 83.89B 32.6B 425B 33.16B 32.47B 1,406B
Net Debt 19.84B 27.04B 23.18B 21.7B 37.43B 2,588B 37.82B 257B 99.74B 1,300B 101B 99.34B 4,302B 17.06B 23.26B 19.93B 18.66B 32.19B 2,226B 32.52B 221B 85.77B 1,118B 87.23B 85.43B 3,699B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
18.90GBP
Average target price
21.69GBP
Spread / Average Target
+14.72%

Quarterly revenue - Rate of surprise